Moderna accepted $2.5 billion in taxpayer money to develop its COVID-19 vaccine. But officials in the U.S. and overseas are having trouble persuading the company to license its technology.
Coronavirus
New York Times: Pressure grows on US companies to share COVID vaccine technology
A nurse takes a Moderna Covid-19 vaccines ready to be administered at a vaccination site at Kedren Community Health Center, in South Central Los Angeles, California on Feb. 16, 2021.
